FDA Approved: XERMELO — Original Application (Lexicon Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved XERMELO (telotristat ethyl) from Lexicon Pharmaceuticals as the original NDA (NDA 208794) for reducing bowel movements in adults with carcinoid syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Syndrome

Drugs mentioned

• XERMELO (telotristat ethyl)

Snippet

ORIG AP for XERMELO (TELOTRISTAT ETHYL)